Skip to content
Screener

Xilio Therapeutics, Inc. XLO Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue$2.9MMiss by $20.3M
EPS-$0.18Beat by $2.52
Revenue estimate$23.2M
EPS estimate-$2.70

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$4.8M
EPS estimate-$0.82

FAQ

When did Xilio Therapeutics, Inc. report Q1 2025 earnings?
Xilio Therapeutics, Inc. (XLO) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Xilio Therapeutics, Inc.'s Q1 2025 revenue and EPS?
Xilio Therapeutics, Inc. reported revenue of $2.9M and eps of $-0.18 for Q1 2025.
Did Xilio Therapeutics, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $23.2M by $20.3M. EPS beat the consensus estimate of $-2.70 by $2.52.
How did Xilio Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 71.0% from $-0.62.
Where can I find Xilio Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-006852) and the 10-Q periodic report (0001558370-25-006996) directly on SEC EDGAR. The filing index links above go to sec.gov.